Dianthus Therapeutics is a clinical-stage biotechnology company based in New York City and Waltham, Mass. Focused on developing novel monoclonal antibodies with enhanced selectivity and potency, the company aims to create transformative medicines for severe autoimmune and inflammatory diseases. Led by an experienced team of biotech and pharma executives, Dianthus is pioneering next-generation antibody complement therapeutics.
Dianthus Therapeutics, a clinical-stage biotech company, is seeking a Director of Clinical Development Scientist to support the APAC region's Myasthenia Gravis (gMG) program. This role involves leading clinical study preparation, review, and execution, as well as ensuring adherence to GCPs and SOPs. The ideal candidate will have experience with rare diseases or neurology and a strong understanding of regulatory requirements.
Dianthus Therapeutics is a clinical-stage biotechnology company based in New York City and Waltham, Mass. Focused on developing novel monoclonal antibodies with enhanced selectivity and potency, the company aims to create transformative medicines for severe autoimmune and inflammatory diseases. Led by an experienced team of biotech and pharma executives, Dianthus is pioneering next-generation antibody complement therapeutics.
Ascendis Pharma